Table 1.

Hematological parameters.

Group	WBC (×103 Cells/μL)	WBC Differential Counting (%)
		Neutrophil	Lymphocyte	Monocyte	Eosinophil	Basophil	Large Unstained Cell
NC	3.77 ± 0.47	22.24 ± 1.49	72.72 ± 1.59	0.70 ± 0.14	1.76 ± 0.21	0.26 ± 0.07	2.32 ± 0.40
DfE	2.39 ± 0.11 #	39.85 ± 3.66 ###	60.24 ± 6.43	1.10 ± 0.18	2.72 ± 0.38 #	0.46 ± 0.14	1.62 ± 0.34
NHGR200	2.43 ± 0.12	22.26 ± 2.71 ***	73.42 ± 2.63	0.78 ± 0.12	1.90 ± 0.13 *	0.48 ± 0.12	1.18 ± 0.32
NHGR400	2.98 ± 0.34	25.18 ± 0.90 **	69.78 ± 0.91	1.10 ± 0.19	1.48 ± 0.10 **	0.40 ± 0.04	2.06 ± 0.51
Dexa5	2.23 ± 0.13	36.38 ± 3.32	57.22 ± 3.74	1.42 ± 0.28	3.10 ± 0.39	0.38 ± 0.06	1.50 ± 0.38

WBC, white blood cells; NC, normal control; DfE, Dermatophagoides farinae extract; NHGR, S. grosvenorii residual extract (200 or 400 mg/kg); Dexa, dexamethasone (5 mg/kg). ^# p < 0.05 and ^### p < 0.001 indicate significant differences between the normal control and DfE-treated atopic dermatitis mice. * p < 0.05, ** p < 0.01, and *** p < 0.001 indicate significant differences between the DfE-treated atopic dermatitis mice and the NHGR- or Dexa-administrated group.